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Alterations in NGF/TrkA signaling have been suggested to underlie the selective
degeneration of the cholinergic basal forebrain neurons occurring in vivo in AD
(Counts and Mufson, 2005; Mufson et al., 2008; Niewiadomska et al., 2011) and
significant reduction of cognitive decline along with an improvement of cholinergic
hypofunction have been found in phase I clinical trial in humans affected from mild
AD following therapeutic NGF gene therapy (Tuszynski et al., 2005, 2015). Here, we
show that the chronic (10–12 D.I.V.) in vitro treatment with NGF (100 ng/ml) under
conditions of low supplementation (0.2%) with the culturing serum-substitute B27
selectively enriches the basal forebrain cholinergic neurons (+36.36%) at the expense
of other non-cholinergic, mainly GABAergic (−38.45%) and glutamatergic (−56.25%),
populations. By taking advantage of this newly-developed septo-hippocampal neuronal
cultures, our biochemical and electrophysiological investigations demonstrate that the
early failure in excitatory neurotransmission following NGF withdrawal is paralleled by
concomitant and progressive loss in selected presynaptic and vesicles trafficking proteins
including synapsin I, SNAP-25 and α-synuclein. This rapid presynaptic dysfunction:
(i) precedes the commitment to cell death and is reversible in a time-dependent manner,
being suppressed by de novo external administration of NGF within 6 hr from its initial
withdrawal; (ii) is specific because it is not accompanied by contextual changes in
expression levels of non-synaptic proteins from other subcellular compartments; (ii) is not
secondary to axonal degeneration because it is insensible to pharmacological treatment
with known microtubule-stabilizing drug such paclitaxel; (iv) involves TrkA-dependent
mechanisms because the effects of NGF reapplication are blocked by acute exposure
to specific and cell-permeable inhibitor of its high-affinity receptor. Taken together, this
study may have important clinical implications in the field of AD neurodegeneration
because it: (i) provides new insights on the earliest molecular mechanisms underlying
the loss of synaptic/trafficking proteins and, then, of synapes integrity which occurs
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in vulnerable basal forebrain population at preclinical stages of neuropathology; (ii) offers
prime presynaptic-basedmolecular target to extend the therapeutic time-window of NGF
action in the strategy of improving its neuroprotective in vivo intervention in affected
patients.
Keywords: basal forebrain, septo-hippocampal primary cultures, cholinergic neurons, Alzheimer’s Disease
(AD), nerve growth factor (NGF), synaptic transmission, electrophysiological recordings, morphological and
biochemical analyses
INTRODUCTION
Synaptic dysfunction is a prodromal event in Alzheimer’s disease
(AD) pathogenesis occurring before neuronal death (Selkoe,
2002) and is more strongly correlated with progressive cognitive
impairment than either plaque or tangle pathology (DeKosky and
Scheff, 1990; DeKosky et al., 1996; Sze et al., 2000; Scheff et al.,
2006, 2007). The basal forebrain system, including the septal
region, plays an important role in memory/learning regulating
the excitability of the hippocampus and neocortex and is
preferentially affected in the initial stages of AD neuropathology
(Mesulam, 2004; Schmitz et al., 2016). Cholinergic neurons,
which strictly depend on their survival, neuritic outgrowth
and phenotype differentiation from target-derived nerve growth
factor (NGF) (Hartikka and Hefti, 1988a,b), are progressively
reduced in affected patients in correlation with cognitive
impairment (Davies and Maloney, 1976; Whitehouse et al.,
1982; Wilcock et al., 1982; Lehéricy et al., 1993), supporting
the hypothesis that their early-stage disturbance and, in turn,
the associated decline in cholinergic innervation of cortical
areas are seminal events for cognitive dysfunction occurring
in AD. In fact there is a phenotypic downregulation but
not a frank loss of cholinergic basal forebrain population in
early AD (Grothe et al., 2012, 2013), suggesting that these
neurons remain still alive although atrophic up to later stages
of the disease progression and, thus, potentially amenable
to pharmacotherapeutic interventions aimed to prevent or
delay the cognitive/behavioral impairment characterizing the
symptomology of this disorder (Mesulam, 2004; Mufson et al.,
2008). Consistently, an impaired signaling of NGF is causally
linked to selective and extensive loss of central cholinergic
functions (Counts and Mufson, 2005; Schliebs and Arendt,
2006; Williams et al., 2006) and NGF replacement therapy
has recently emerged as a new promising safety and efficacy
disease-modifying treatment for cognitive recovery in patients
with mild AD (Tuszynski et al., 2005, 2015; Mufson et al.,
2008). In line with the modulatory role of NGF on amyloid
precursor protein (APP) secretory pathway(s) in NGF-responsive
cells (Rossner et al., 1998; Isacson et al., 2002; Matrone et al.,
2008a,b; Calissano et al., 2010a,b), the ectopic administration
of NGF stimulates the binding of its high-affinity receptor
TrK kinase A (TrkA) to Amyloid Precursor Protein (APP)
in in vitro cholinergic septal neurons favoring its subcellular
localization in Golgi compartment—via downregulation in
phosphorylation at the threonine 668 (T668)—which, in turn,
reduces susceptibility to BACE cleavage and promotes the anti-
amyloidogenic processing (Triaca et al., 2016). NGF supply
via nasal route has been proved to in vivo modulate the
secretase levels and, in turn, reduce the amyloid burden in
APP/PS1 transgenic mice (Yang et al., 2014) and transgenic mice
lacking the APP-TrkA interaction display forebrain damage and
cognitive deficits (Matrone et al., 2012). Cholinergic neurons
located in the nucleus basalis of Meynert of affected subjects
exhibit a great sensibility to undergo neurofibrillary degeneration
at early stages of AD neuropathology (Sassin et al., 2000;
Mesulam et al., 2004), suggesting that NGF is also able to
influence the tau metabolism, in addition to its effects on
basal forebrain cholinergic function(s) and on APP processing
(Schliebs and Arendt, 2006). Finally, phenotypic knockout of
NGF via its antibody-mediated neutralization in adult transgenic
AD11 mice causes age-dependent neurodegenerative changes
which are reminiscent of human AD pathology characterized
by severe deficits in basal forebrain cholinergic neurons,
classic histopathological hallmarks including amyloid plaques
and tau neurofibrillary tangles in cortical and hippocampal
neurons, behavioral deficits (Capsoni et al., 2000). Therefore,
in view of the physiopathological relevance of NGF/TrkA
signaling dysfunction in triggering the initial AD-type lesions of
vulnerable cholinergic basal forebrain population which critically
contribute to memory/learning impairment of hippocampal
and cortical areas (Mesulam, 2004), the understanding of the
earliest molecular events following neurotrophin starvation
in cholinergic septo-hippocampal system will support the
development of novel disease modifying drugs aimed to
slow down the conversion from asymptomatic Mild Cognitive
Impairment (MCI) MCI to clinical full-blown dementia (Mufson
et al., 2012).
Although a crucial involvement of early alterations in
the NGF/TrkA system in driving neurodegeneration of
basalforebrain at the onset of AD progression has been largely
accepted, studies carried out on primary septohippocampal
cultures have turned out to be technically challenging mainly
due to the scarse yield of the cholinergic and TrkA-positive
neuronal population transplanted in vitro with consequent
difficulties in assessing the specificity, the precise timing
and, if possible, the reversibility of any biochemical events
triggered by NGF withdrawal. By biochemical, morphological
and electrophysiological approaches, here we show that the
selective reduction of B27(0.2%), the most widely-used serum-
free supplement in culture media, combined with chronic
somministration of NGF (100 ng/ml), added immediately after
plating and for 10–12 days in vitro (D.I.V.), significantly
increases the number of cholinergic neurons in septal
primary cultures (+36.36%) at the expense of non-cholinergic,
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mainly glutamatergic (−56.25%) and GABAergic (−38.45%),
populations. The frequency of spontaneous excitatory miniture
post-synaptic currents (mEPSCs) is significantly stimulated upon
exposure to ectopic NGF in septohippocampal cultures under
conditions of low B27(0.2%) media, confirming that a large
amount of cholinergic and NGF-responsive neurons are actually
enriched following this experimental procedure. Importantly, by
taking advantage of this newly-developed neuronal paradigm,
we uncover that the withdrawal of NGF induces a progressive
deficit in the presynaptic excitatory neurotransmission which
occurs in concomitance with a pronounced and time-dependent
reduction in several distinct pre-synaptic markers, such as
synapsin I, SNAP-25 and α-synuclein, and in absence of any
sign of neuronal death. This rapid presynaptic dysfunction: (i) is
reversible in a time-dependent manner, being suppressed by de
novo external administration of NGF within 6 h from its initial
withdrawal; (ii) is specific because it is not accompanied by
contextual changes in expression levels of non-synaptic proteins
from other subcellular compartments; (ii) is not secondary to
axonal degeneration because it precedes the post-translational
modifications of tubulin subunits which critically control the
cytoskeleton dynamics and is insensible to pharmacological
treatment with known microtubule-stabilizing drug such
paclitaxel; (iv) involves TrkA-dependent mechanisms because
the effects of NGF reapplication are blocked by acute exposure to
specific and cell-permeable inhibitor of its high-affinity receptor.
Taken together, these findings suggest that this novel protocol
based on defined medium of cell culture provides—with
good approximation to the in vivo conditions—a significant
enrichment/selection in mature and NGF-responsive cholinergic
neurons of septal basal forebrain populations, representing thus
a unique and relevant in vitro AD-relevant model to study the
alteration in NGF/TrkA signaling occurring in the vulnerable
affected population at pre-symptomatic prodromal stages of
disorder. In addition, and more importantly, our results reveal
that NGF deprivation acts via TrkA-activation directly and locally
on neurosecretory function of cholinergic presynaptic terminals
by controlling the steady state levels of synapsin I, SNAP25 and
α-synuclein, helping to devise rational therapies that early targets
the vulnerable basalforebrain projection system in order to delay
and/or reduce the onset of MCI and,ultimately, of clinical AD.
MATERIALS AND METHODS
Chemical Compounds
Picrotoxin and strychnine were purchased from Sigma (St.
Louis, MO) and were dissolved in EtOH and water, respectively.
Tetrodotoxin (TTX) was from Alomone Labs (Jerusalem, Israel).
DHβE, CNQX and D-AP5 were from Tocris Bioscience (Bristol,
UK) and were dissolved in water. NGF was purified from
submaxillary glands (Bocchini and Angeletti, 1969). NGF from
Xiamen Bioway (Biotech Co., Ltd., Xiamen, Fujian, China)
was also used in the study. Recombinant monoclonal antibody
to Nerve Growth Factor αD11 (Cattaneo et al., 1988) was
generously given from A.Catteneo. TrkA inhibitor GW441756
was from Tocris (Bristol, UK).
The drugs were diluted to their final concentration with
the extracellular solution and, unless otherwise stated, the
compounds to be tested were added to the perfusion solution.
In a separate series of experiments we ensured that final
concentration of EtOH had no effect on evoked responses.
Solutions containing DHβE, CNQX, D-AP5, and NGF were
applied using a multibarrel pipette gravity perfusion system
controlled by electronic valves positioned near the soma of the
recorded neuron using a fast perfusion system (SF-77B Warner
Ins., Hamden, CT, USA; Hatton et al., 2003).
The following antibodies were used: TrkA antibody (763)
rabbit sc-118 Santa Cruz; Trk B antibody (794) rabbit sc-
12 Santa Cruz; p75 rabbit N3908 Sigma-Aldrich; mAChR
M1 antibody (H-120) rabbit sc-9106 Santa Cruz; choactase
antibody (H-95) rabbit sc-20672 Santa Cruz; anti-Choline
Acetyltransferase antibody goat AB144P Millipore; NMDAζ1
antibody (C-20) goat sc-1467 Santa Cruz; PSD95 antibody
(clone 7E3-1B8) mouse MAB1598 Millipore; PSD95 antibody
(clone 6G6-1C9) mouse ADI-VAM-PS002-E EnzoLife Science;
vGLUT1 antibody rabbit 135,302 Synaptic System; anti-vGAT
antibody rabbit 131,003 Synaptic System; mGluR2 antibody
rabbit PPS050 RD System; Anti-NeuN antibody (clone A60)
mouse MAB377 Millipore; Tau antibody (H-150) rabbit sc-
5587 Santa Cruz; Anti-MAP-2 antibody (clone AP20) mouse
MAB3418 Millipore; Anti-Synapsin I antibody rabbit AB1543P
Millipore; Anti-SNAP-25 antibody (clone SMI 81) mouse 836301
BioLegend; anti-α-synuclein antibody (clone 42) mouse 610786
BD Transduction Laboratories; Dynamin antibody mouse
610246 BD Transduction Laboraories; synaptophysin antibody
(D-4) mouse sc-17750 Santa Cruz; anti-syntaxin 1mouse S1172
Sigma-Aldrich; Calnexin antibody (C-20) goat sc-6465 Santa
Cruz; VDAC1 antibody (B-6) mouse sc-390996 Santa Cruz;
Tom20 antibody (FL-145) rabbit sc-11415 Santa Cruz; acetylated
α Tubulin (6-11B-1) mouse sc-23950 Santa Cruz; rat anti
tubulin alpha mouse MCA77G Bio-Rad; Anti-caspase 3 cleaved
(active) form antibody rabbit AB3623 Millipore; AβPP antibody
aa 66-81 (22C11) mouse MAB348 Millipore; AβPP antibody
(4G8) aa 18-22 of the Aβ peptide mouse Covance SIG39220;
GAPDH antibody (clone GAPDH-71.1) mouse G8795 Sigma-
Aldrich; β-actin mouse S3062 Sigma-Aldrich; anti-mouse IgG
(whole molecule)-Peroxidase antibody A4416 Sigma-Aldrich;
anti-rabbit IgG (whole molecule)-Peroxidase antibody A9169
Sigma-Aldrich; donkey anti-goat IgG-HRP antibody sc2056
Santa Curz.
Animals
Pregnant Wistar rats (Charles River Laboratories) at gestational
age 17-18 (E17-18) were used for all the experiments of this study.
Experimental protocols were carried out in accordance with
the European Communities Council Directive of 22 September
2010 (2010/63/UE) regarding the care and use of animals for
experimental procedures and with the Italian legislation on
animal experimentation (Decreto L.vo 116/92).
Septal Neurons Primary Cultures
Septal neurons were prepared from embryonic day 17/18
(E17/18), as previously described (Hartikka and Hefti, 1988a,b)
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with some modifications. Briefly, embryos were surgically
removed and septo-hippocampal areas were dissected from the
cerebral tissue in ice-cold Hanks’ balanced salt solution (HBSS,
Gibco, Life Technologies), freed of meninges, digested with
0.25% trypsin for 15 min at 37◦C, dissociated by trituration and
seeded as follows: 2× 106 cells on poly-l-lysine (SIGMA)-coated
plates (BD Falcon, Durham, NC, USA; 353001) for biochemistry
analyses and 10 × 104 cells on glass coverslips in 24-well
plates (BD Falcon; 351147) for immunofluorescence analyses.
The dissociated cells were plated serum-free Neurobasal medium
(Gibco, Life Technologies) supplemented with B27 (Invitrogen
Inc., Carlsbad, CA, USA) at final 2 or 0.2% concentration in
the presence of NGF (100 ng/ml) for 10–12 days. One day
after plating, cytosine arabinoside (5µM) was added to inhibit
glial proliferation. Cultures were kept at 37◦C in a humidified
incubator in a 5% CO2 atmosphere without further medium
changes until used for experiments.
Assessment of Neuronal Viability
Cell viability was quantified by assessing cytomorphological and
biochemical alterations, including the count of the number of
apoptotic nuclei (Loo and Rillema, 1998), the mitochondrial
MTT tetrazolium salt assay (Manthorpe et al., 1986), the
Western blotting detection of active cleaved caspase-3 (Asp175)
(Srinivasan et al., 1998).
Immunofluorescence
Following treatment, septohippocampal cultures were washed
twice with PBS and fixed in 4% (w/v) paraformaldehyde for 15
min at room temperature. Cells were permeabilized with 0.1%
(v/v) Triton X-100/PBS pH 7.4 for 4 min at room temperature.
Coverslips were saturated with 2% BSA and 10% normal goat
serum (NGS) for 3 h followed by incubation overnight at 4◦C
in a humidified chamber with primary antibodies. Unbound
antibody was removed by three washes and bound antibody was
detected by incubation with donkey anti-mouse-488 and donkey-
anti-rabbit-555 IgG from Jackson ImmunoResearch (1:300),
or donkey anti-goat-488 and donkey-anti-rabbit-594 from Life
Technologies (1:500) at room temperature for 30 min. Nuclei
were stained with nuclear marker 4,6-diamidino-2-phenylindole
dihydrochloride (DAPI; Sigma, St. Louis, MO, USA) 1:1,000 in
PBS for 5 min and samples were mounted on glass slides, and
cover slipped with antifademedium. Controls were performed by
omitting either the primary or the secondary antibody. Images
are representative of at least three independent experiments
and were acquired with an Eclipse 80i Nikon Fluorescence
Microscope (Nikon Instruments, Amsterdam, Netherlands).
Protein Cellular Lysates Preparation
Total proteins were extracted by scraping the cells in ice-cold
RIPA buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% NP40,
0,1% SDS, 5% sodium deoxicholate plus proteases inhibitor
cocktail (Sigma Aldrich, P8340) and phosphatase inhibitor
cocktail (SigmaAldrich, P5726/P2850) and centrifuged at 4◦C for
20min at 13,000 rpm. The supernatant was then collected and
the amount of total protein was determined by Bradford assay
(Protein Assay Dye Reagent Concentrate, BioRad, Hercules, CA,
USA).
SDS-PAGE, Western Blot Analysis and
Densitometry
Equal amounts of protein were separated by SDS-PAGE in 4–
12% Bis-Tris gels (Invitrogen), and transferred to nitrocellulose
membranes (0.45µm, GE healthcare, Little Chalfont, UK).
The filters were blocked in TBS-T containing 5% non-
fat dried milk for 1 h at room temperature or overnight
at 4◦C. Proteins were visualized using appropriate primary
antibodies. All primary antibodies were diluted in TBS-T
and incubated with the nitrocellulose blot overnight at 4◦C.
Incubation with secondary peroxidase coupled anti-mouse,
anti-rabbit or anti-goat antibodies was performed by using
the ECL system (Thermo Scientific SuperSignal West Pico,
34080; Amersham ECL Prime, RPN2232). Protein loading was
monitored by normalization to β-actin. Blots were scanned
and quantitative densitometric analysis was performed by using
ImageJ (http://imagej.nih.gov/ij/).
Electrophysiological Recordings
Whole cell patch-clamp recordings were performed from 10
to 12 day-old in vitro (D.I.V.) primary septum neurons to
study the excitatory neurotransmission under different culture
conditions (Caioli et al., 2011). Particularly, the neurons were
voltage clamped at −60 mV. The recording pipettes were pulled
from borosilicate glass with an outer diameter of 1.2 mm and had
open tip resistances of 3–5 M. The internal solution for filling
pipettes consisted of (inmM): 140 CsCl, 1 EGTA, 10 HEPES, 6 D-
glucose (pH 7.4 with CsOH). The standard extracellular solution
consisted of (in mM): 130 NaCl, 3 KCl, 2 MgCl2, 1.5 CaCl2, 10
HEPES, 6 D-glucose, and 10 tetraethyl-ammonium (TEA) Cl (pH
7.4 with NaOH).
To isolate the miniature Excitatory Post Synaptic Currents
(mEPSCs), 0.5µM tetrodotoxin (TTX), 5µM strychnine,
100µM picrotoxin were added in the bath solution, in order
to block voltage-dependent Na+ currents, glycine and GABAA
receptors, respectively. Recordings were carried out for 5 min
from each neuron and the last 2 min of each recording were
analyzed.
In order to evaluate the contribution of the cholinergic and
glutamatergic activity in the excitatory neurotransmission, the
competitive nicotinic acetylcholine receptor antagonist dihydro-
β-erythroidine hydrobromide (DHβE; 50µM) was applied to
some neurons. In particular, following 3min of total mEPSC
recording (control condition), DHβE was applied to each neuron
for 3 min and the last 2min of each recording were analyzed. The
remaining mEPSCs were abolished completely by 5µM6-cyano-
7-nitroquinoxaline-2,3-dione (CNQX) and 10µMD-2-amino-5-
phosphonovalerate (D-AP5).
In some experimental conditions, the short term effect of NGF
on mEPSCs was tested by applying NGF (100 ng/ml) directly on
the recorded neurons. Following 3min of total mEPSC recording
(control condition), NGF was acutely applied for 3min and the
last 2min of each recording were analyzed. In some experiments,
TrkA inhibitor (15µM) was added to the culture medium
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for 20min, prior to start the electrophysiological experiments,
and then was added to the extracellular solution, in order to
selectively block the NGF receptor.
Experiments were performed at room temperature (22–
24◦C). After the formation of a high-resistance seal (>1 G),
the capacitance and the resistance of the electrodes were
compensated electronically. Recordings were made using a
MultiClamp 700B amplifier (Axon CNS, Molecular Device).
pCLAMP 9.2 software was utilized for the data acquisition system
(Axon Instruments). The whole cell capacitance was assessed
online using the Membrane test function of pClamp9.2. Current
signals were sampled at 100 kHz and filtered at 3 kHz.
Data Analysis
Data presented are representative of at least three independent
experiments and were expressed as mean ± SEM. Statistical
analysis of all the experiments in this study were performed by
GraphPad Prism (GraphPadSoftware), SPSS 17.0.0 for Windows
(SPSS Inc., Chicago, IL, USA), Origin 7.0 (Microcal Software,
Northampton, MA, USA) using appropriate test, i.e., paired
or unpaired Student’s t-test and One-Way ANOVA followed
by Bonferroni post hoc correction. Results were considered
significant when p < 0.05. To analyze miniature post synaptic
currents (mEPSCs), the 6.0.7 version of Mini Analysis Program
(Synaptosoft Inc., Decatur, GA, USA) was used. mEPSCs were
manually detected using a 8 pA threshold crossing algorithm.
Frequency, event amplitude, kinetic characteristics (rise and
decay time), and event area were compared between the different
experimental conditions.
RESULTS
Chronic NGF Treatment of
Septo-Hippocampal Cultures in 0.2% B27
Media Selectively Enriches for Cholinergic
and TrkA-Expressing Target Neuronal
Population
The medial septal region (medial septum and diagonal band
of Broca, MS/DB), which controls hippocampal excitability
and synaptic plasticity associated to learning and memory
(Olton et al., 1978; Poucet and Herrmann, 1990; Dutar et al.,
1995; Niewiadomska et al., 2009), includes different neuronal
subpopulations with heterogeneous morphology, biochemical,
electrophysiological properties and connectivity. In fact, a
detailed characterization of the in vivo septo-hippocampal
projections has recently given strong evidence of three distinct
neurotransmitter pathways including GABAergic (27.8%),
cholinergic (47%) and glutamatergic (24.5%) neurons (Colom
et al., 2005, 2013; Wu and Yeh, 2005; Huh et al., 2008). However,
as cholinergic neurons represent only a part of distinct neuronal
subpopulations located in the septo-hippocampal circuit (Colom
et al., 2005, 2013; Huh et al., 2008; Teles-Grilo Ruivo and Mellor,
2013), basic and pharmacological AD research will benefit from
their selective and robust enrichment in order to be studied in the
absence of any other neuronal and non-neuronal contaminants.
On the other hand, the setting-up of an experimental method
which provides with a high-degree of homogeneity good yields
of septal primary cultures fully-mature at both morphological
and functional levels is particularly troublesome to technically
overcome because post-mitotic neurons do not proliferate.
Therefore, with the intent of developing a novel in vitro tool
which both ricapitulated the in vivo conditions and enabled
to assess without any confusing off-target effects the direct
action of NGF starvation on a more consistent and genuine
cholinergic population, primary neurons from dissociated
septal sections of fetal (E17) rat containing MS/DB basal
forebrain area were chronically maintained in culture media
with different concentrations of B27 supplementation (2%,
0.2%) in the absence or in presence of exogenously-added
NGF (100 ng/ml). Importantly, the in vitro experimental
paradigm we used in the present work has been designed to
ensure that the specific action of extracellularly-added NGF
was restricted to its physiological target population. In fact,
since cholinergic neurons of the basal forebrain are the only
ones in the brain to constitutively express both the requisite
Tropomyosin kinase A (TrkA) and p75 neurotrophin (p75NTR)
receptors (Sobreviela et al., 1994), they are uniquely sensitive
to administration of ectopic NGF. After 10–12 D.I.V., Western
blotting analysis on total protein extracts were performed by
probing with antibodies against specific markers of cholinergic
(TrkA high-affinity NGF receptor, p75NTR low-affinity NGF
receptor, TrkB BDNF receptor, muscarinic acetylcholine
receptor M1, choline acetyltransferase ChAT) glutamatergic
(N-methyl-D-aspartate glutamate receptor 1 NR1, vesicular
glutamate transporter 1 vGLUT-1) and GABAergic (vesicular
γ-AminoButyric transporter vGAT) phenotypes to compare the
extent of each neuronal-type population among three different
culture conditions (2% B27, 2% B27+NGF, 0.2% B27+NGF). As
shown in Figure 1 by biochemical characterization and relative
densitometric quantification, septal primary neurons grown for
10–12 D.I.V in classic media supplemented with 2% B27 and
in the absence of NGF (2% B27experimental group) showed
a sizeable but detectable expression of three different well-
confirmed cholinergic-specific markers such as M1, ChAT and
TrkA (Dawbarn et al., 1988; Holtzman et al., 1992; Sobreviela
et al., 1994), in line with previous findings reporting that
differentiation and initial survival of central NGF-responsive
neurons in the early postnatal period can occur even in the
absence of NGF (Crowley et al., 1994; Ruberti et al., 2000) and
that glial astrocytes are able to synthesize NGF and secrete it in
culture (Lindsay, 1979; Norrgren et al., 1980; Furukawa et al.,
1986). The addition of exogenous NGF (100 ng/ml) for the same
period of time (10–12 D.I.V.) to B27-rich cultures media (2%
B27+NGF experimental group) increased the specific expression
profile of cholinergic phenotype of septal neurons, consistent
with its renowned and potent action in positively stimulating
the differentiation of the target responsive population in high-
density cultures of basal forebrain (Hartikka and Hefti, 1988a,b;
Kew and Sofroniew, 1995). Interestingly, we found out that a
more robust upregulation in M1,ChAT, and TrkA protein levels
was detected when neuronal population was shifted to media
supplemented with lower B27 concentration and in the presence
of extracellular NGF (100 ng/ml; 0.2% B27+NGF experimental
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FIGURE 1 | Biochemical characterization in the expression profile of glutamatergic, GABAergic cholinergic phenotype-specific markers in
septohippocampal cultures grown in the chronic presence of NGF (100ng/ml) under different conditions of B27 supplementation. Western blotting
analysis (n = 9) was carried out on equal amounts of total protein extract (20–80µg) from septal primary neurons cultured for 10–12 D.I.V. in defined medium
supplemented with 2% B27 or 0.2% B27, in the presence or absence of exogenously-added NGF (100 ng/ml) Immunoblots were probed with antibodies against
specific markers of cholinergic (TrkA high-affinity NGF receptor, p75NTR low-affinity NGF receptor, TrkB BDNF receptor, muscarinic acetylcholine receptor M1, choline
acetyltransferase ChAT) glutamatergic (N-methyl-D-aspartate glutamate receptor 1 NR1, vesicular glutamate transporter 1 vGLUT-1) and GABAergic (vesicular
γ-AminoButyric Acid transporter vGAT) phenotypes to compare the extent of each neuronal population among three different culture conditions. Cropped
representative WB are shown. Molecular weights are indicated on the right of the blots and expressed in kDa. Densitometric quantification of immunoreactivity levels
were calculated by normalizing the values on the intensity ratio of β-actin, as loading control for each sample/lane, and NeuN, as neuron-specific marker to minimize
the glial cells component (less than 5%). Dashed line indicates the bands used for the quantification. Values are mean ± standard error of the mean (SEM) of at least
nine independent experiments and are expressed with respect to B27 2% control neurons. Statistically significant differences were calculated by unpaired-two tailed
t-Student’s test (*p < 0.05, **p < 0.01 and ***p < 0.0001). Note that the defined medium supplemented with 0.2% B27 in the chronic (10–12 D.I.V.) presence of NGF
(100 ng/ml) promotes the selective enrichment in cholinergic NGF-responsive neuronal population in septo-hippocampal primary cultures.
group) in comparison with sister 2% B27 control cultures.
Conversely, the immunoreactivity of other not-cholinergic
markers -such as NR1, vGLUT-1 and vGAT- was contextually
reduced in 0.2% B27+NGF experimental group, suggesting
that this newly-developed culture procedure relying on lower
B27 supplementation was actually able to enrich for a
more copious NGF-responsive cholinergic septo-hippocampal
population. Furthermore, the extent of TrkB expression—
another neurotrophic tyrosine kinase receptor which also
supports the survival and phenotypic differentiation of basal
forebrain cholinergic neurons upon interaction with BDNF
in a ligand-specific manner (Alderson et al., 1990)—was not
positively affected following this culture protocol consistent
with previous findings showing that rat septal cultures that
respond to BDNF or NGF are closely overlapping but not the
similar populations (Alderson et al., 1990; Colom et al., 2005).
Likewise, no significant change was contextually detected in
the intensity signal of the low-affinity NGF receptor p75NTR,
in line with the observation that 95% of septal cholinergic
neurons express TrkA (Sobreviela et al., 1994) and that p75NTR
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does not play a major in vivo role in the maintenance of the
number or morphology of medial septum cholinergic neuron
(Ward et al., 2000). It’s worth pointing out that, although
NGF is capable of stimulating both the mRNA and the protein
expression of its own receptor(s) (Montero and Hefti, 1988;
Higgins et al., 1989; Holtzman et al., 1992) and the enzymes
associated with regulation of acetylcholine amount (ChAT and
AChE) (Honegger and Lenoir, 1982; Gnahn et al., 1983; Mobley
et al., 1986; Alderson et al., 1989; Li et al., 1995), only the
long-term somministration of exogenous NGF for 10–12 D.I.V.
combined with a lower concentration of B27 supplementation
turned out to be effective in significantly improving the cell-
type density, likely in a synergistic way. Taken together, these
findings suggest that the selective enrichment in cholinergic
population under adverse in vitro conditions of lower doses of
nutrients is to be ascribed to the de novo induction in expression
of NGF-stimulated specific markers in close association with
its survival action on TrkA-expressing responsive neurons, as
supported by the significant diminution in viability (ranging
from 30 to 60%, as assessed by MTT assay and Hoechst
nuclei staining respectively) we detected comparing the two
experimental groups kept continously in presence of NGF
for 10–12 D.I.V. but in media supplemented with different
concentrations of B27 (Supplentary Figure 1). Furthermore, an
unknown soluble nutritional B27 component -perhaps insulin-
may also act in addition to NGF as general growth factor being
able to maintain the in vitro survival of all three neuronal
populations but not the phenotype of cholinergic neurons, in
line with previous observations (Svendsen et al., 1994; Kew and
Sofroniew, 1995).
Next, in order to better visualize the actual size of
cholinergic and non-cholinergic -mainly glutamatergic and
GABAergic- subpopulations under these three different in vitro
culture conditions (2% B27, 2% B27+NGF, 0.2% B27+NGF),
we carried out a morphological chracterization of septo-
hippocampal neurons by double-immunocytochemistry analysis
with an antibody against microtubule associated protein 2
MAP2 -a neuron-specific marker which decorates perikarya
and dendrites processes- in association with one of the
three different phenotype-selective antibodies directed against
TrkA, vGLUT1, vGAT respectively. As shown in Figures 2A–C
and consistently with Western blotting results, a selective
and substantial reduction in the proportion of vGLUT-1 or
vGAT-positive neurons was detected when septal cultures
were exposed for 10–12 D.I.V. to 100 ng/ml NGF in 0.2%
B27 media (−56.25 and −38.45%, respectively). Furthermore,
under these growth conditions, cell number quantification
(Figures 2E,F) showed a noteworthy increase in the total
number of neurons which were double-stained for MAP-2 and
ChAT, indicating a marked enrichment (+36.36%) in NGF-
sensitive cholinergic population whose percentage has known
to be very low in basal forebrain primary cultures when
long-term kept in canonical high-concentrated 2% B27 culture
media (Hartikka and Hefti, 1988a,b; Alderson et al., 1990;
Svendsen et al., 1994). To better characterize the identity of
cholinergic population, a double-immunocytochemistry analysis
for the two phenotype-specific ChAT and TrkA markers
(Dawbarn et al., 1988; Holtzman et al., 1992; Sobreviela
et al., 1994) was also performed on septal neurons cultured
under these different in vitro conditions from plating. As
shown in Figure 2D, in 2% B27 culture media both in
the absence and presence of exogenous NGF, only few
ChAT/TrkA- double positive neurons could be detected in
vitro ranging from 1 to maximally 5% of all cell population,
as previously reported (Hartikka and Hefti, 1988a,b; Svendsen
et al., 1994). In contrast, prolonged NGF treatment in
media supplemented with low 0.2% B27 nutrients significantly
increased the number per dish- and to some degree the
staining intensity as well- of individual cholinergic neurons
decorated with diffuse ChAT and TrkA immunolabeling which
codistributed with similar pattern along cell-body and neuritic
processes of both high and low caliber (Figure 2D, arrows
and arrowheads respectively). In line with previous findings
(Hartikka and Hefti, 1988a,b; Svendsen et al., 1994), we
confirmed that in vitro septal cholinergic neurons usually
displayed rounded cell bodies and were larger than those
expressing other neurotransmitter(s) whose shape included
oval and polygonal/pyramidal configurations, although the
punctated immunoreactivity pattern of vGAT and vGLUT1
antibodies made sometimes difficult the univocal visualization
of neuronal soma. Furthermore and consistent with previous
reports (Hartikka and Hefti, 1988a,b; Colom et al., 2005),
all ChAT-positive neurons were also costained for TrkA and
did not immunoreact with vGLUT-1 and vGAT with the
exception of a small minority of neurons that were labeled
with more than one single antibody, as we also detected in
our triple immunolabeling analysis (data not shown). Finally,
an evident increase in proportion of dense heterochromatin
nuclei was detected in neuronal cultures grown in 0.2%
B27+NGF media in keeping with the cell viability assays
(Supplementary Figure 1), supporting thus the notion that
when septal cultures were maintained for long periods of
time (10–12 D.I.V.) under these in vitro conditions which
favored survival and morphological features of cholinergic
phenotype a gradual and selective loss of non-cholinergic
neurons at the expense of ChAT and TrkA-positive population
occurred.
Taken together, our biochemical and morphological results
demonstrate that: (i) treatment with NGF(100 ng/ml) under
in vitro conditions of low 0.2% B27 nutrients selectively keeps
alive forebrain cholinergic neurons at the expense of all other
non-cholinergic resident populations—mainly GABAergic
(−38.45%) and glutamatergic (−56.25%)—accounting for
their progressive significant enrichment (+36.36%) in primary
septal cultures after 10–12 D.I.V.; (ii) the combined survival-
and growth-enhancing selection sustained by the ectopic
addition of NGF in the presence of 0.2% B27 supplementation
provides a simple, less expensive and valuable method to
obtain a consistent and genuine cholinergic population
which can be advantageous for in vitro studies aimed to
investigate the survival/disease changes of basal forebrain
septo-hippocampal projections occurring during the prodromal
stages of AD pathology and caused by dysfunction in NGF/TrkA
signaling.
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FIGURE 2 | Selective reduction in the size of non-cholinergic, mainly glutamatergic and GABAergic, neuronal populations are detected in septal
neurons exposed for 10–12 days in vitro to 100ng/ml NGF in B27 0.2% culturing medium. (A–D) Confocal microscopy analysis of double
immunofluorescence carried out on septohippocampal primary neurons cultured for 10–12 D.I.V. in defined medium supplemented with 2% B27 or 0.2% B27, in the
presence or absence of exogenously-added NGF (100 ng/ml). Merge images show the overlay of the two fluorescence channels. Staining for dendritic MAP-2 enabled
to visualize the integrity of neuritic network whereas labeling for phenotype-selective marker was used to identify the extent of each specific neuronal population in
septal primary cultures. (A) Dendritic MAP-2 (green channel) and glutamatergic-specific marker vGLUT-1 (red channel); (B) Dendritic MAP-2 (green channel) and
GABAergic-specific marker vGAT (red channel); (C) Dendritic MAP-2 (green channel) and cholinergic-specific marker ChAT (red channel); (D) Two cholinergic-specific
markers, ChAT (green channel) and TrkA (red channel). Nuclei (blue) were stained with Hoechst 33258 (0.5 mg/ml). Note the loss in vGLUT1- and vGAT-positive
neurons under the B27 0.2% +NGF experimental conditions of culturing media. Images are representative of at least three independent experiments. Scale bar:
10µM. (E,F) Graph represents the averaged number ± SEM. (n = 5–10) of of vGLUT1- vGAT- and ChAT-positive neurons per 100 X image-field in septohippocampal
cultures grown in the chronic presence of NGF(100 ng/ml) under different conditions of B27 supplementation. The number of each cell type was counted under
conditions of B27 2% nutrients and compared with the number present in sister wells grown B27 0.2%-supplemented media. Statistically significant differences were
calculated by unpaired-two tailed t-Student’s test (*p < 0.05 and ***p < 0.0001 between corresponding cell numbers at the experimental time-point). Table represents
the mean of number distribution (number of cells/cm2 ) and % variation of neurons present in the defined medium at the experimental time-point. Means ± SEM. are
given. These results demonstrate a significant increase in cholinergic neurons (+36.36%) at the expense of all other non-cholinergic populations of septum -mainly
GABAergic (−38.45%) and glutamatergic (−56.25%) populations.
Long-Term In vitro Cholinergic Neurons
Cultured in the Presence of NGF under
Conditions of 0.2% B27 Supplementation
Acquire Mature Electrophysiological
Properties That Closely Resemble Those of
In vivo Central Nervous System (CNS)
Neurons
Compelling evidence has proved that in vivo intraseptal infusion
of NGF influences the cholinergic neuronal morphology,
hippocampal plasticity and behavior in the intact rat brain,
suggesting that one of the physiological functions of this
neurotrophic factor in adult CNS is the dynamic modulation
of strength of cholinergic projections to hippocampal/cortical
targets and, ultimately, of the neuronal plasticity (Conner et al.,
2009). In support of this statement, it has been demonstrated
that an increase in NGF availability significantly stimulates the
septal cholinergic cell function(s) and facilitates the induction of
hippocampal long-term potentiation (LTP) whereas its reduction
suppresses cholinergic-type markers (Sofroniew et al., 1990)
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and impairs retention of spatial memory (Conner et al., 2009).
In keeping with its in vivo neuromodulatory function, it has
also been shown that NGF is able to selectively facilitate the
synaptic transmission of cholinergic basal forebrain primary
neurons without affecting the other resident noncholinergic
populations- mainly glutamatergic and GABAergic- which
express different neurotransmitter phenotypes (Wu and Yeh,
2005; Huh et al., 2008). Consistently, chronic exposure of
MS-DB primary cultures to NGF leads to an increase in the
neurotransmitter release but not in the density of postsynaptic
receptors—likely by rapid control of local protein synthesis
(Kang and Schuman, 1996; Melemedjian et al., 2010)—indicating
that this neurotrophin is able to exert a potent and specific
stimulatory presynaptic action on cholinergic nerve terminals
(Huh et al., 2008). In view of these observations, the status of
excitatory neurotransmission of septo-hippocampal neurons
cultured under media conditions of B27 0.2% supplementation
in the chronic presence of NGF (100 ng/ml) was investigated
in order to check whether the ensuing cholinergic-enriched
population was also endowed with appropriate functional
properties of NGF responsiveness. To this aim, we performed
electrophysiological recordings of spontaneous miniature
excitatory post-synaptic currents (mEPSCs), which are largely
accepted to rise from random release of presynaptic vesicles
at nerve endings and to play important roles in maintaining
functional connections of synaptic terminals (Caioli et al., 2011;
Saba et al., 2016).
In Figure 3A are reported representative mEPSCs of septo-
hippocampal neurons kept for 10–12 D.I.V. under different
culture conditions, including B27 2%, B27 2%+NGF, B27 0.2%,
and B27 0.2%+NGF, recorded at the holding potential −60 mV
(see methods for details). As shown in Figure 3B, the mean of
the mEPSC frequencies was significantly reduced in neurons
grown in conditions of low B27 supplementation (B27 0.2%:
0.63 ± 0.06Hz; n = 30) in comparison with sister cultures kept
for the same duration with a high dose of B27 nutrients (B27
2%: 1.32 ± 0.21Hz; n = 16; B27 2%+NGF: 1.35 ± 0.11Hz,
n = 11 p < 0.01, One-Way ANOVA). These results indicate
that the extent of excitatory neurotransmission of septal neurons
was per se significantly affected by the diminution of the B27
concentration regardless of the modulatory presynaptic effect
of NGF, likely due to its negative impact on cell survival that
we detected to be less than 30% in in vitro conditions of B27
0.2% alone (data not shown). Interestingly, exogenously-added
NGF (100 ng/ml) was able to strongly enhance the excitatory
neurotransmission when septo-hippocampal populations were
chronically grown in its presence under B27 0.2% conditions,
as evidenced by the fact that the mean of mEPSC frequencies
of neurons kept in B27 0.2%+NGF medium (1.38 ± 0.16HZ;
n = 35) was significantly higher to that of corresponding
sister cultures maintained under conditions of B27 0.2% alone
(p < 0.05, One-Way ANOVA). Furthermore, no significant
difference was detected in the average of mEPSCs frequencies
between septal cultures kept in B27 0.2%+NGF medium and
those grown under conditions of high B27 nutrients (2%), both
in the presence and absence of NGF (p > 0.05, One-Way
ANOVA).
Finally, in line with previous data reporting a specific effect
of this neurotrophin on in vitro cholinergic neurons at the
presynaptic level (Wu and Yeh, 2005; Huh et al., 2008), the mean
amplitude as well as the mean area and the kinetic parameters
of the mEPSCs were not modified, both by B27 medium
concentrations and by treatment with exogenous NGF (p> 0.05,
One-Way ANOVA). The findings that the averaged frequency
of miniture events detected in neuronal cultures grown under
conditions of 0.2% B27 + NGF, despite a consistent reduction
in their cell viability (30–50%) which per se could negatively
impact on the extent of recorded afferent inputs (Supplementary
Figure 1), was comparable to that of corresponding ones kept in
B27 2% independently of the presence of extracellularly-added
NGF, clearly indicated that a larger proportion of cholinergic
and, then, uniquely NGF-responsive (Sobreviela et al., 1994)
neurons was actually in vitro enriched following this culture
protocol.
In order to quantify the relative contribution of the
cholinergic and glutamatergic neurotransmission in the mEPSCs
recorded in 0.2% septum primary neurons,we pharmacologically
isolated the two components by means of DHβE (50µM),
a selective competitive nicotinic receptor antagonist, and
CNQX (5µM) and D-AP5 (10µM), two potent competitive
antagonist of AMPA/kainate receptor and NMDA receptor
respectively. In detail, for each neuron the total mEPSCs were
recorded for 3 min, DHβE was applied for the following
3 min and then the remaining glutamatergic mEPSCs were
analyzed for the last 2 min of each recording. Next, the
activity was further blocked by CNQX (5µM) and D-AP5
(10µM) and the mEPSC frequency post-DHβE perfusion
was normalized with that in control condition for each
neuron to quantify the glutamatergic component of mEPSCs,
while the remaining component was considered as cholinergic
activity.
As shown in Figures 4A,B, the mEPSCs recorded in B27
0.2% septum neurons were almost completely due to the
glutamatergic neurotransmission (97.3 ± 3.8%; n = 8) because
the cholinergic one represented only a small component (3.3
± 3.8%) of the total excitatory activity. On the contrary, under
conditions of B27 0.2%+NGF, the glutamatergic component
was significantly lower (61.2 ± 1.7%; n = 8; p << 0.001
unpaired Student’s t-test) and the cholinergic component
inversely higher (38.8 ± 1.7%; p << 0.001 unpaired Student’s
t-test) than those measured in B27 0.2% neurons (Figure 4B),
in line with our previous biochemical and morphological data
(Figures 1, 2) indicating that the cholinergic neurons thrived
when cultured in 0.2% B27 medium in the chronic presence of
ectopic NGF.
These results indicate that: (i) septohippocampal neurons
cultured for 10–12 D.I.V. in the chronic presence of NGF
under conditions of 0.2% B27 supplementation are a highly-
enriched population of cholinergic neurons expressing
phenotype-specific markers (Figures 1, 2) which acquire a
mature neuronal morphology along with NGF-dependent
neurophysiological functional properties, just resembling
the in vivo NGF-responsive TrkA-expressing neurons in
CNS.
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FIGURE 3 | Septal primary neurons cultured for 10–12 D.I.V. in defined medium supplemented with 0.2% B27 and in the presence of exogenous NGF
(100ng/ml) acquired NGF-dependent neurophysiological properties, just resembling those of in vivo mature cholinergic neurons. (A) Representative
traces of mEPSCs recorded from septal neurons grown for 10–12 D.I.V. in B27 2%, B27 2%+NGF, B27 0.2%, and B27 0.2%+NGF culture media. (B) Bar plots
report the mean ± SEM frequency, amplitude, rise time, decay time and area of the mEPSCs recorded under different experimental conditions. Primary cultures grown
in B27 0.2%+NGF medium (B27 0.2%+NGF: 1.38 ± 1.16 Hz) showed averaged mEPSC frequency significantly higher than that from neurons kept in B27 0.2% (B27
0.2%: 0.63 ± 0.06 Hz, n = 30) whereas not significant difference was found in comparison to B27 2% and B27 2%+NGF (B27 2%: 1.32 ± 0.21 Hz, n = 16; B27
2%+NGF: 1.35 ± 0.11 Hz, n = 11). Values are means of at least four independent recordings and statistically significant differences were calculated by One-Way
ANOVA followed by Bonferroni’s correction. (**p < 0.01 vs. B27 2% and B27 0.2%+NGF); (*p < 0.05, vs. B27 2%+NGF). No significant differences were detected for
the other analyzed parameters.
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FIGURE 4 | Cholinergic neurons cultured in 0.2% B27-supplemented media and in the chronic (10–12 D.I.V) presence of exogenously-added NGF (10
ng/ml) expressed mEPSCs with larger frequency than control cholinergic population kept for the same duration under conditions of 2% B27 nutrients
(A) Representative traces of septal primary neurons grown for 10–12 D.I.V. in B27 0.2% and in B27 0.2%+NGF, in basal settings, following DHβE (50µM; 3 min) and
DHβE+CNQX (5µM)+D-AP5 (10µM) perfusion (3 min). (B) Bar plots report the mean ± SEM percentage of glutamatergic and cholinergic frequencies from total
mEPSCs recorded under the different culture conditions. In B27 0.2%-supplemented media, the mEPSCs were due for the largest part to the glutamatergic
neurotransmission (glutamatergic: 97.3 ± 3.8%; cholinergic: 3.3 ± 3.8%; n = 8) whereas, after chronic treatment of cultures with exogenously-added NGF, a
significant decrease in the glutamatergic component of mEPSCs (61.2 ± 1.7%; n = 8) was detected in correlation with an increase of the cholinergic one (38.8 ±
1.7%). Values are means of at least four independent cultures and statistically significant differences were calculated by unpaired Student’s t-test (***p < 0.001).
NGF Withdrawal Induces an Early,
Selective and Reversible Deterioration of
Cholinergic Presynaptic Terminals, Just
Resembling the “Dying-Back”-Like
Mechanism(s) of Cell Degeneration of
Basal Forebrain Circuit Occurring In vivo
during AD Neuropathology and Caused by
Neurotrophin Starvation
Synapses loss and retrograde “dying-back” axonal
degeneration—where loss of terminals ends precede somatic cell
death—are characteristic features of several neurodegenerative
diseases, including AD, appearing at prodromal stages of
pathology in correlation with incipient memory dysfunction
(Griffin and Watson, 1988; Mandelkow et al., 2003; Roy
et al., 2005; Overk and Masliah, 2014). In cognitively healthy
elderly individuals with suspected non-Alzheimer’s disease
pathophysiology (SNAP) or in patients with amnestic MCI,
cholinergic basal forebrain neurons may be viable, although
dysregulated, but do not display a massive and frank loss making
them a valuable target of NGF-based therapeutic approaches
aimed to prevent and/or delay the cognitive deterioration
starting from the earliest stages of symptomology (Mufson et al.,
2008). Therefore, with the intent of investigating the earliest
and potentially reversible molecular events that occur within
12 h following withdrawal of NGF and compromise AD neurons
prior to initiation of cell death, mature 10–12 D.I.V., septal
cholinergic-enriched cultures grown continuously in 0.2% B27
media in the presence of exogenous NGF (100 ng/ml) from
plating were deprived of their trophic support for different
periods of time (−1.5,−3,−6,−12,−24 h). By Western blotting
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analysis on total protein extracts, we evaluated the steady-
state levels of different markers of synaptic and cytoskeleton
compartments which are known to be greatly affected during
the initial NGF-dependent “dying-back”-like mechanisms of
cell degeneration occurring in vivo at the earliest stages of AD
neuropathology (Stokin and Goldstein, 2006; Kanaan et al.,
2013).
As shown (Figures 5A–E) and in line with the evidence that
presynaptic proteins are not equally affected in human AD brains
(Sze et al., 2000; Honer, 2003; Reddy et al., 2005), the withdrawal
of NGF caused in this in vitro neuronal paradigm an early
(starting from −1 h), gradual and significant decline (∗p < 0.05,
∗∗p < 0.01 vs. t = 0) in a few relevant presynaptic proteins -such
as synapsin I, synaptosomal-associated protein 25 (SNAP-25) and
α-synuclein which are essential for neurosecretion and synaptic
plasticity, being involved in local trafficking of synaptic vesicles
and/or Ca2+-triggered neurotransmitter release. In contrast,
other proteins located in the same subcellular compartment
-such as dynamin, synaptophysin, syntaxin, mGluR2 -were
contextually unmodified up to 24 h and even after incubation
with αD11, a specific NGF-neutralizing monoclonal antibody
(Cattaneo et al., 1988) which has been previously reported to
reduce availability and to antagonize its biological functions in
vivo (Capsoni et al., 2000; Ruberti et al., 2000; Covaceuszach et al.,
2008). These progressive dysfunctional changes were not due to
a general, non-specific deterioration in protein amount/quality
taking place in the absence of any appreciable cell death up
to 48 h, as we previously assessed by MTT assay and Western
blotting detection of active cleaved caspase-3 (Supplementary
Figure 2). Furthermore, the dramatic changes in the regulation
of protein expression and/or stability occurring early following
NGF deprivation turned out to be strictly limited to presynaptic
terminals because: (i) no substantial and simultaneous alteration
in the intracellular amounts of twomajor postsynaptic proteins—
such as N-Methyl-D-aspartate (NMDA) Receptor subunit 1
(NR1) and postsynaptic density protein 95 (PSD95)—was
contextually evident when NGF was removed in cholinergic-
enriched septal primary neurons; (ii) the expression levels of
several not-synaptic proteins—including specific markers of
endoplasmic reticulum and mitochondria such as calnexin,
VDAC, Tom20 located in different subcellular compartments
of cell-body—were also unaffected in these cultures despite
prolonged (−24 h) antibody-mediated immunodepletion of NGF
trophic support. Only after 48 h of NGF removal and in
concomitance with the appearance of marked deterioration
signs characterized by an evident neurite degeneration and pre-
apoptotic fragmented and heterochromatic nuclei, we detected a
significant and general drop in amounts of synaptic markers in
this in vitro neuronal paradigm (data not shown). Interestingly,
we did not measure any change in immunoreactivity of either
pre- or post-synaptic proteins when sister basal forebrain
primary neurons chronically grown for the same length of time
(10–12 D.I.V.) in the presence of NGF but in conditions of
rich media (2% B27+NGF experimental group) were deprived
of their trophic support up to 24 h (Supplementary Figure 3)
in support of the notion that these presynaptic events occurring
under condition of 0.2% B27 took place for the large part in the
cholinergic-enriched and then NGF-dependent population. In
agreement with our previous results (Figures 1, 2), these findings
clearly demonstrated that the present newly-developed culture
protocol (0.2% B27+NGF for 10–12 D.I.V.) really enriched with
a good degree of homogeneity for a consistent, genuine and
highly NGF-responsive population representing thus an useful
tool for more specific in vitro assessment of the early AD-
relevant, cholinergic-based processes associate with the loss in
NGF/TrkA signaling. In fact, the number of non-cholinergic
neurons—which are not sensible to NGF and greatly differ
in proportion between cultures grown under the two diverse
conditions of B27 supplementation (Figures 1, 2)—was not
obviously decreased following neurotrophin starvation, thus
taking into account of the significant experimental differences
observed. In striking similarity with the in vivo observations that
is the initial loss in synaptic contacts occurring at the earliest
stages of typical AD neuropathology which triggers the following
“dying-back” degeneration progressing retrogradely from distal
terminal ends to perikaryon and nucleus (Kanaan et al., 2013),
this prompt presynaptic failure was not secondary tomicrotubule
network disassembly but preceded the axonal degeneration
because: (i) no significant post-translational modifications of
tubulin subunits which critically control the cytoskeleton
dynamics were concomitantly found in vitro up to 6 h of
NGF withdrawal, as assessed by Western blotting analysis with
antibodies against acetyl (stable)- and tyrosinated (instable)-
tubulin (data not shown); (ii) NGF-deprived septal neurons
were insensible to pharmacological treatment with known
microtubule-stabilizing drugs as evidenced by the observation
that the signal intensity of SNAP25, synapsin I and α-synuclein
was not rescued when cultures were 30 min preincubated with
5 nM paclitaxel before the NGF withdrawal (Figures 6A,B).
Importantly when cholinergic neurons grown in 0.2% B27
media in the chronic presence of exogenous NGF, were
deprived of their trophic support for increasing periods of time
(−1,−3,−6,−12,−24 h) and then re-exposed to it up to 24 h,
we found out that these NGF-dependent presynaptic deficits
were virtually abrogated (Figures 5A–E) for the reason that the
loss in protein amounts of synapsin I, SNAP25 and α-synuclein
was strongly suppressed by its de novo external re-application
up to 6 h from initial withdrawal (∗p < 0.05, ∗∗p < 0.01 vs.
corresponding NGF-deprived sample). However, the control of
NGF on the cholinergic pre-synaptic stability was reversible but
in a time-dependent manner because the dramatic decline in
endogenous levels of these three relevant neurosecretory proteins
was no longer sensitive to its exogenous re-application if it was
delayed for 12 or 24 h (data not shown), indicating the existence
of a critical and restricted period after that most cholinergic
neurons become independent on their specific target-derived
growth factor and irreversibly committed to degenerate.
Collectively, our results demonstrate that: (i) a marked,
simultaneous and sequential downregulation in the expression
levels of several distinct presynaptic proteins involved in vesicles
trafficking and neurotransmitter release -such as synapsin I,
SNAP25 and α-synuclein- occurs in mature cholinergic septal
cultures at early time-points following the NGF withdrawal;
(ii) these NGF-deprived in vitro neurons, just as those which
selectively degenerate in the early stages of AD neuropathology
owing to alterations in NGF/TrkA survival signaling, retain
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FIGURE 5 | Early and selective presynaptic deficits of cholinergic presynaptic terminals occur at early time points of NGF withdrawal in
septo-hippocampal primary neurons in the absence of global changes in other synaptic and non-synaptic proteins. (A–E) Septal cholinergic-enriched
cultures grown continously in 0.2% B27 media in the presence of exogenous NGF (100 ng/ml) from plating were deprived of their trophic support for different periods
of time (−1.5, −3, −6 h) in the presence or in absence of specific neutralizing anti-NGF αD11 monoclonal antibody (800 ng/ml). At the time points indicated, cell were
either harvested or re-exposed to NGF (100 ng/ml) and further kept up to 24 h when they were eventually collected. Equal amounts of total protein extract (40–80µg)
were resolved on SDS-PAGE gels and immunoblots were probed with antibodies directed against relevant presynaptic proteins (A–C) -including synapsin I,
synaptosomal-associated protein 25 (SNAP-25), α-synuclein, dynamin, synaptophysisn, syntaxin, mGluR2-, post-synaptic markers (B) -such as N-methyl-D-aspartate
glutamate receptor 1 (NR1) and postsynaptic density protein 95 (PSD95)- and not-synaptic proteins located in cytosol, endoplasmic reticulum and mitochondria (D)
-glyceraldehyde 3-phosphate dehydrogenase (GAPDH), calnexin, voltage-dependent anion channel (VDAC/Porin), translocase of outer membrane (Tom20). Cropped
representative WB are shown. Molecular weights are indicated on the right of the blots and expressed in kDa. Densitometric quantification of immunoreactivity levels
(E) was calculated by normalizing the values on the intensity of β-actin, as loading control for each sample/lane. Values are mean ± SEM of at least nine independent
experiments and are expressed with respect to B27 0.2% control neurons at t = 0 (t0) (
◦) and at corresponding time (t = −1, −3, −6 h) of NGF deprivation (§).
Statistically significant differences were calculated by unpaired-two tailed t-Student’s test (*p < 0.05, **p < 0.01, and ***p < 0.0001).
their ability to respond and re-activate specific biochemical and
functional NGF-stimulated cell pathway(s) but only for a critical
period of time.
Pharmachological Disruption of TrkA
Signaling Abolishes the NGF-Induced
Effects on Presynaptic Markers and
Function
An imbalance between the TrkA-mediated survival signaling
and the p75NTR-mediated pro-apoptotic signaling has been
hypothesized to compromise the cholinergic basal forebrain
neuronal function(s) during the prodromal stages of AD
(Counts and Mufson, 2005; Mesulam, 2013). Consistently,
a partial activation of TrkA can upregulate the cholinergic
phenotype of the basocortical projection system and improve
cognition, in the absence of p75NTR activation (Bruno et al.,
2004). Next, in order to study the pathological relevance
of these NGF-dependent alterations in the context of in
vivo AD neurodegeneration and considering that the MS/DB
cholinergic neurons—but not noncholinergic ones—largely
(>95%) express the high-affinity TrkA receptor, which makes
them selectively sensitive to direct action of NGF (Sobreviela
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FIGURE 6 | Loss of presynaptic terminals in NGF-deprived cholinergic neurons is accompanied by pathological alterations in microtubule-dependent
axonal stability. (A,B) Representative blots (n = 5) of detergent lysates from septal cholinergic-enriched cultures which were grown continously in 0.2% B27 media
in the presence of exogenous NGF (100 ng/ml) from plating and then deprived of their trophic support for 6 h. At time points indicated, cell were either harvested or
incubated with 5 nM paclitaxel, a microtubule-stabilizing drug, and further kept up to 24 h when they were eventually collected (F). Densitometric quantification of
immunoreactivity levels (G) was calculated by normalizing the immunoreactive signals of each band to corresponding β-actin intensities on the same blots.
Modifications of tubulin subunits were contextually evaluated, by probing filters with antibodies directed against acetyl (stable)- and tyrosinylated (instable)- tubulin in
order to check the cytoskeleton dynamics. Note that, in contrast to re-application of NGF, treatment with paclitaxel is not able to rescue the immunoreactivity signals
of the two selected presynaptic proteins following 6 h neurotrophin starvation. Statistically significant differences were calculated by unpaired-two tailed t-Student’s
test (*p < 0.05, **p < 0.01).
et al., 1994; Sanchez-Ortiz et al., 2012), we investigated
whether the potent actions of NGF in controlling both
the steady-state levels of selected presynaptic proteins and
the neurotransmission were causally linked and occurred via
activation of signaling of TrkA whose expression levels we
detected to be significantly up-regulated under 0.2% B27+
NGF in in vitro conditions (Figures 1A,B). First of all,
having established that the withdrawal of NGF in 0.2% B27
cholinergic neurons was able to cause a rapid and time-
dependent downregulation in the expression levels of several
presynaptic proteins involved in vesicles trafficking, we set
about checking whether the NGF-dependent increase in the
frequency of mEPSCs—which is associated to the augmented
probability of exocytosis of synaptic vesicles at presynaptic
terminals rather than to postsynaptic responses (Huh et al.,
2008)—was also concomitantly affected in this in vitro paradigm
upon neurotrophin starvation. As shown in Figures 7A,B
and in correlation with the rapid and selective decline in
immunoreactivity of SNAP25, synapsin I and α-synuclein as
we detected by Western blotting analysis (Figures 5A–E), we
uncovered that- in the absence of any change in cell viability
which occurred only after 48 h of deprivation (Supplementary
Figure 1)- the averaged frequency of mEPSCs was significantly
lower in 0.2% B27 cholinergic neurons following short-term
removal of exogenous NGF for 3–6 h (3 h: 0.66 ± 0.08Hz,
n = 22; 6 h: 0.59 ± 0.05 Hz, n = 16; p < 0.001, One-
Way ANOVA) in comparison with control B27 0.2%+NGF
cultures (1.39 ± 0.16Hz, n = 35). On the contrary, the mean
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FIGURE 7 | NGF withdrawal provoked a rapid and time-dependent reduction of excitatory neurotransmitter release in septal-cholinergic primary
neurons. (A) Representative traces of septal cholinegic cultures grown for 10–12 D.I.V. in B27 0.2%+NGF and deprived for 3 and 6 h of NGF trophic support. (B) Bar
plots reporting the mean ± SEM frequency of the recorded mEPSCs displayed a significant reduction in mEPSCs frequency detected in in vitro cholinergic-enriched
neurons following 3 h (0.66 ± 0.08 Hz; n = 22) and 6 h of NGF removal (0.5 ± 0.05 Hz; n = 16) in comparison with B27 0.2%+NGF control ones (1.38 ± 0.16 Hz;
n = 35). Values are means of at least four independent cultures and statistically significant differences were calculated by One-Way ANOVA followed by Bonferroni’s
correction (**p < 0.01 vs. 0.2% B27+NGF).
amplitude as well as the mean area and the kinetic parameters
of the mEPSCs were not modified by NGF deprivation (data
not shown), in line with previous findings (Huh et al.,
2008).
Next, in order to assess the potential causal relationship
between these two concomitant NGF-triggered events, 0.2%
B27+NGF cultures deprived for 6 h of their trophic support
were re-exposed to it- in the presence or absence of GW441756
a potent, selective and cell-permeable inhibitor of TrkA (Wood
et al., 2004)- and then the expression levels of SNAP25, synapsin
I and α-synuclein along with the efficacy in neurotransmitter
release were assessed in parallel, by Western blotting analysis
and electrophysiological recording of mEPSCs respectively
(Figure 8). Figure 8A displays the representative mEPSCs
recorded at the holding potential −60 mV in B27 0.2%+NGF
neurons following 6 h deprivation before and after the acute
perfusion of exogenous NGF (100 ng/ml), in the presence or in
absence of GW441756 TrkA inhibitor (15µM, −20 min). As
shown in Figure 8B, the averaged mEPSCs frequency measured
in cholinergic neurons cultured in B27 0.2% supplementation
in the chronic presence of NGF following 6 h deprivation was
significantly enhanced by its de novo acute perfusion (pre:
0.51 ± 0.1 Hz; post: 1.16 ± 0.36Hz, n = 8; p < 0.01,
paired Student’s t-test) whereas not significant difference was
detected in comparison to B27 0.2%+NGF controls (p > 0.05
unpaired Student’s t-test) which, as expected, were not sensible
to NGF acute perfusion (pre: 1.55 ± 0.11 Hz; post: 1.54 ±
0.15Hz, n = 6; p > 0.05 paired Student’s t-test). Interestingly
the acute effect of NGF infusion on mEPSC frequencies was
completely blocked by 20min pretreatment with GW441756
inhibitor, indicating that NGF exerted its presynaptic facilitation
of neurotransmitter release via TrkA-mediated mechanism(s)
(pre: 0.55 ± 0.07 Hz; post: 0.58 ± 0.05Hz, n = 12; p > 0.05,
paired Student’s t-test). Furthermore and more importantly we
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found out that the concomitant up-regulation in expression
levels of presynaptic marker SNAP25 evoked by re-application
of exogenous NGF to 6 h-deprived cholinergic neurons was
also greatly prevented by blocking the TrkA/NGF signaling
with GW441756 inhibitor, as shown by Western blotting
on total protein extracts from treated cultures (Figure 8C).
Similar results were detected for the other two presynaptic
proteins, synapsin I and α-synuclein (data not shown). The
efficacy of GW441756 in negatively affecting the initial event
of NGF/TrkA signal transduction was also checked by probing
with specific antibody against TrkA (Y490) phosphorylation
(data not shown) which is largely known to occur rapidly upon
exposure to NGF in primary septal neurons (Triaca et al.,
2016). These results clearly demonstrated that the combined
modulatory actions of NGF on the presynaptic morphology
and neurosecretory function(s) of in vitro cholinergic septal
primary neurons were directly and causally linked via the
stimulation of NGF/TrkA signaling (Figures 8A–C), pointing
out the pathological relevance of the lack in NGF availability
in the earliest synaptic deficits occurring at the onset of AD
progression.
Taken together, our biochemical and electrophysiological
results demonstrate that blocking NGF/TrkA signaling
decreases the probability of exocytosis of synaptic
vesicles at presynaptic terminals likely by downregulating
the steady-state levels of relevant presynaptic proteins
which critically control the vesicular trafficking and
neurotransmission, including synapsin I, SNAP25 and
α-synuclein.
DISCUSSION
A growing number of cellular and animal studies suggests
that AD is a synaptic failure and begins with subtle alterations
of hippocampal synaptic efficacy prior to frank neuronal
degeneration (Selkoe, 2002). Compelling in vitro and in vivo
evidence supports a pivotal role for an imbalance between
TrkA-mediated survival signaling and p75NTR-dependent
pro-apoptotic pathway in triggering the selective atrophy
of cholinergic septo-hippocampal population occurring in
prodromal stages of AD neuropathology (Counts and Mufson,
2005; Niewiadomska et al., 2011; Schliebs and Arendt, 2011;
Grothe et al., 2014). Furthermore, morphological investigations
carried out on experimentally lesioned animals and on
postmortem human brain tissues have demonstrated that most
basal forebrain cholinergic neurons, although downregulated
in their phenotypic markers, persist in an atrophic state during
the AD progression rather than degenerate, being thus suitable
to effective drug treatment or neuroprotective strategies aimed
to prevent/attenuate the cognitive dysfunction associated to
degeneration of their projections to cortical areas (Mufson
et al., 2008; Potter et al., 2011). In line with previous reports
(Sassin et al., 2000; Mesulam et al., 2004; Grothe et al., 2013;
Kilimann et al., 2014), longitudinal studies of anatomical
magnetic resonance imaging (MRI) performed on AD patients
at different stages of neuropathology have recently confirmed
that presymptomatic lesions of cholinergic neurons of nucleus
basalis of Meynert precede the earliest memory impairments,
indicating that therapeutic strategies targeting the basal forebrain
will actually offer promising opportunities in delaying and/or
prevent the transition from MCI to frank AD (Potter et al.,
2011; Schmitz et al., 2016). In AD brains, the intracerebral
level of NGF appears to be stable or even increased in cortex,
whereas a significant reduction is detected in basal-forebrain
cholinergic population (Mufson et al., 1995; Scott et al., 1995),
in support of the conclusion that the early perturbation in
NGF/TrkA signaling occurring within cholinergic vulnerable
areas is more likely to be due to defective retrograde transport
of this target-derived neurotrophin to its responsive neurons
(Salehi et al., 2004; Counts and Mufson, 2005). Consistently,
infusion of NGF can prevent septal cholinergic neuron death
following septo-hippocampal axotomy (Hefti, 1986; Williams
et al., 1986; Tuszynski and Gage, 1995) and AD11 transgenic
mice engineered to express anti-NGF neutralizing antibody
in adulthood display a severe and age-dependent loss of
ChAT-positive basal forebrain neurons (Capsoni et al., 2000;
Ruberti et al., 2000). Perturbation in the excitatory-inhibitory
balance of neural circuitries early occurs within the adult
AD11 hippocampi (Lagostena et al., 2010), just resembling the
initial compensatory alteration in neurotransmission observed
in AD pathology which progressively contributes itself to
exacerbate the correlated cognitive deficits by disrupting of
the overall network activity (Palop et al., 2007). In addition
to cholinergic loss and hippocampal-dependent memory
deficits, the activation of amyloidogenic APP cascade with
intra/extracellular accumulation of Aβ peptide(s) along with the
dysmetabolism (hyperphosphorylation/cleavage) of tau are also
detected in animal and cellular neuronal models undergoing
NGF withdrawal which recapitulate a comprehensive AD-like
neuropathology (Capsoni et al., 2000; Ruberti et al., 2000;
Matrone et al., 2008a,b; Houeland et al., 2010; Amadoro et al.,
2011; Triaca et al., 2016). These important findings support the
“neurotrophic model” which states that the reduced availability
of NGF is more likely to be an upstream driver for in vivo AD
neurodegeneration, by linking all its typical histopathological
signs into a common neurodegenerative cascade (Cattaneo
and Calissano, 2012). Furthermore, provided that the potent
stimulatory effect of synaptic vesicles exocytosis evoked by
NGF on presynaptic nerve endings is unique to cholinergic
neurons (Huh et al., 2008), the alterations in NGF/TrkA
signaling in this vulnerable septo-hippocampal population
may actually play a critical role in promoting the synaptic
derangements and neurotransmission deficits occurring in MCI
and at early stage of AD pathology (Cattaneo and Calissano,
2012). In this framework, any data strengthening the causal
molecular link between NGF dyshomeostasis and early-stage
AD features could be helpful in assisting the development
of more effective neuroprotective and disease-modifying
non-invasive cholinergic therapy for the amelioration of AD
symptomology.
The present study explores the early synaptic mechanisms
underlying the failure in neurotransmission provoked by the lack
of NGF trophic supply, which is causally involved in selective
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FIGURE 8 | NGF induced a facilitation of presynaptic excitatory neurotransmitter release from cholinergic septal neurons by acting on TrkA receptor.
(A) Representative traces of septal neurons grown for 10–12 D.I.V. in B27 0.2%+NGF, deprived for 6 h of NGF, in the presence and in the absence of GW441756
TrkA inhibitor (15µM), in basal settings (left) and following 3 min of NGF acute perfusion (100 ng/ml; right). (B) Bar plots report the mean ± SEM frequency of the
mEPSCs recorded under different experimental conditions, pre and post NGF perfusion. NGF acute perfusion significantly increased the mEPSC frequency in 6 h
(Continued)
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FIGURE 8 | Continued
deprived neurons (pre: 0.51 ± 0.1 Hz; post: 1.16 ± 0.36 Hz, n = 8; p < 0.01, paired Student’s t-test) but was not effective in B27 0.2%+NGF neurons (pre: 1.55 ±
0.11 Hz; post: 1.54 ± 0.15 Hz, n = 6; p > 0.05 paired Student’s t-test) and when GW441756 TrkA inhibitor was added to solutions (pre: 0.55 ± 0.07 Hz; post: 0.58
± 0.05 Hz, n = 12; p > 0.05, paired Student’s t-test). Values are means of at least three independent cultures and statistically significant differences were calculated
by paired two-tailed Student’s t-test (**p < 0.01, pre- vs. post-NGF perfusion in 6 h-deprived neurons) and by One-Way ANOVA followed by Bonferroni’s correction
(hash (#) p < 0.001 vs. B27 2%+NGF). (C) Representative blots (n = 3) of total lysates from septal cholinergic-enriched cultures which were grown continously in
0.2% B27 media in the presence of exogenous NGF (100 ng/ml) from plating and then deprived of their trophic support for 6 h. At time points indicated, cell were
either harvested or re-exposed to NGF (100 ng/ml) in the presence or absence of GW441756 TrkA inhibitor (15µM) up to 24 h when they were eventually collected.
Densitometric quantification of immunoreactivity levels of presynaptic SNAP25 was calculated by normalizing the immunoreactive signals of each band to
corresponding β-actin intensities on the same blots. Statistically differences were calculated by paired two-tailed t-Student’s test (*p < 0.05; **p < 0.01).
degeneration of septo-hippocampal circuit and AD-associated
cognitive decline, with the following five pertinent findings.
First, we devise a newly-developed culture protocol allowing
with a high-degree of homogeneity a selective enrichment in
the NGF-responsive cholinergic population at the expense of
other noncholinergic septal neurons. By turning to this in vitro
neuronal paradigm, we show that neurotrophin starvation leads
to selective and rapid (−1 h) downregulation in the steady-
state levels of three relevant regulators of presynaptic vesicles
dynamics located at nerve endings, such as synapsin I, SNAP25
and α-synuclein. Second, we demonstrate that these seminal
presynaptic alterations affecting the NGF-dependent cholinergic
neurons of septum anticipate the “dying-back” degeneration
occurring at prodromal/early stages of AD neuropathology
because they are not accompanied by any significant and
concomitant change in microtubule-dependent axonal stability
and neuronal viability. Third, we reveal that the specific changes
in proteome involving the secretory machinery are causally
linked to a parallel decline in the NGF-stimulated frequency
of spontaneous miniature events, suggesting that cholinergic
neurons are functionally downregulated in the absence of
NGF being unable to respond to its stimulatory action at
the presynaptic level. Fourth, we display that the activation
of NGF/TrkA signaling in cholinergic cultures mediates the
regulation of the expression levels of selected presynaptic
proteins -such as synapsin I, SNAP25 and α-synuclein- and,
in turn, of the increase in synaptic neurotransmission. Fifth,
we delineate the existence of critical time window after that
point most of cholinergic neurons are irreversibly committed to
degenerate because the biochemical and functional events above-
described are reversible but only within 6 h from removal of NGF.
Each step will be further discussed in more detail.
Concerning the newly-developed cell culture method we
established (Figures 1–4) it’s noteworthy that, although rat (E17-
E18) septohippocampal primary cultures—which are routinely
kept under 2% B27% or similar growth conditions—were
previously used in biochemical, immunocytochemical and
functional in vitro studies (Hartikka and Hefti, 1988a,b; Alderson
et al., 1990; Svendsen et al., 1994), detailed molecular analyses
have documented that after 10–12 D.I.V. only 1.7–2.1% of all
MAP-2 positive cells in in vitro basal forebrain neurons are truly
cholinergic and NGF-responsive (Hartikka and Hefti, 1988a,b;
Oosawa et al., 1999; Auld et al., 2001). Therefore, considering
that the very low (less than 5%) percentage of yield of cholinergic
neurons following the above-mentioned culture protocol puts
important practical limitations which restrain its wide utilization
in several fields of applications at single cell-type level, the
setting up of optimization methods for reproducing a sufficient
amount of homogeneous phenotype-specific population in
basal forebrain primary cultures represents an important
breakthrough in the reasearch of AD neuropathology. Here,
based on immunocytochemical along with Western blotting
and electrophysiological data, we report that a reduction in
B27 supplementation (0.2%) in the growth media in the
chronic presence of exogenously-applied NGF (100 ng/ml)
produces severalfold (+36.36%) enrichment in ChAT/TrkA-
positive and NGF-dependent cholinergic neurons in 10–12
D.I.V. septal cultures from basal forebrain at the expense of
all other non-cholinergic—mainly GABAergic (−38.45%) and
glutamatergic (−56.25%)—populations. Relevantly, the more
consistent proportion of in vitro septo-hippocampal cholinergic
neurons obtained following this culture protocol is fully mature,
at both morphological and electrophysiological levels, and
therefore, turns out to be particularly useful to: (i) investigate
more accurately and more specifically the physiopathological
cholinergic events occurring at pre-symptomatic stages of AD
neurodegeneration with particular regard to the underlying
synaptic deficits due to alteration in NGF/TrkA signaling; (ii)
test the therapeutic efficacy of external supplementation of NGF
trophic support restricted only to degenerating vulnerable basal
forebrain ChAT-positive neurons which strictly represent in vivo
its target population. In line with previous paper (Hartikka
and Hefti, 1988b), the contribution of endogenous levels of
neurotrophin(s) in this in vitro pure neuronal model of NGF
deprivation is quite negligible, as demonstrated by the fact
that less than 3% of the cell population appears to be of
glial nature (astrocytes) after immunocytochemical staining of
Glial fibrillary acid protein (GFAP) at 12 days after plating.
Furthermore, in support of the finding that the generation of
a more sizable NGF-responsive population will allow a more
accurate in vitro assessment of the AD-related neurodegenerative
processes, our preliminary results (Supplementary Figure 4)
demonstrate that the APP metabolism is greatly influenced
following NGF withdrawal in this novel neuronal paradigm.
In line with previous findings reporting a modulatory effect
of NGF signaling on APP expression (Araki and Wurtman,
1998; Matrone et al., 2008b), a significant upregulation in
expression of its three isoforms of ∼110, ∼120, and ∼130 kDa
was detected in 0.2% B27+NGF septo-hippocampal neurons
upon 48 h of neurotrophin starvation, as shown by Western
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blotting analysis with 22C11 antibody directed against the N-
terminal epitope (aa 66–81) of holoprotein. Furthermore, by
probing with 4G8 antibody which recognizes the residues 18–
23 of the Aβ sequence, we revealed that the NGF-triggered
APP amyloidogenic processing is activated in cholinergic-
enriched 0.2% B27+NGF septohippocampal neurons following
48 h of withdrawal whereas the immunoreactivity level of
the diagnostic carboxyl-terminal βCTF fragment of 14 kDa
appears to be below the threshold of detection in 2% sister
coltures processed at the same point-time and in the same
experimental manner. In line with in vivo evidence concerning
the potential initial role of basal forebrain degeneration in
AD onset/progression (Beach et al., 2000; Roher et al., 2000;
Grothe et al., 2013; Schmitz et al., 2016), these results help
to clarify the important issue concerning the causal role of
the loss in NGF-stimulated TrkA-mediated signaling in the
activation of the pathogenetic amyloid cascade, suggesting that
NGF deprivation is actually able to directly and locally trigger
the amyloidogenic APP processing in responsive cholinergic-
enriched basal forebrain neurons. In view of these investigation
and in agreement with our previous papers (Cattaneo and
Calissano, 2012; Triaca et al., 2016), it is tempting to speculate
that the early degeneration of cholinergic basal forebrain neurons
can initiate the Aβ pathology which, in turn, in vivo trans-
synaptically spread to the neocortex. Alternatively, as suggested
by other investigators (Boncristiano et al., 2002; Salehi et al., 2004;
Schliebs and Arendt, 2006), the production of independently-
generated Aβ peptide may influence the integrity of TrkA-
bearing neurons resulting into disruption of NGF signaling
and, then, of maintenaince of cholinergic basal forebrain
neurons.
By taking advantage of this newly-developed in vitro culture
protocol, our biochemical and electrophysiological approaches
of Western blotting analyses and spontaneous excitatory
postsynaptic currents (EPSCs) recordings (Figures 5–8) on
cholinergic-enriched septal neurons clearly demonstrate that
the reduction of NGF bioavailability is early paralleled by a
selective down-regulation in expression levels of three relevant
presynaptic proteins -such as synapsin I, SNAP25 and α-
synuclein- which limits the responsiveness of presynaptic
terminals to NGF-stimulated synaptic vesicles exocytosis. The
morphological and functional control of NGF on presynaptic
terminals occurs via TrkA-mediated mechanisms and its
deregulation is reversible within a narrow temporal window
because NGF-deprived cholinergic neurons remain able to
respond to delayed NGF somministration until 6 h after
its withdrawal. In agreement with these observations, it has
been reported that the ability of NGF in reverting the
neurodegenerative phenotype in AD11 mice following its in vivo
chronic delivery through olfactory bulb is less effective after 6
months of age (Capsoni et al., 2002) and that the retrograde
NGF/TrkA signaling is necessary and sufficient to promote
the synapses assembly in postganglionic sympathetic neurons
(Sharma et al., 2010). Besides, the work we have presented
is also consistent with compelling evidence showing that the
changes in synaptic structure and function are early markers of
age-linked AD (Terry et al., 1991; Selkoe, 2002; Scheff et al.,
2006, 2007; Nimmrich and Ebert, 2009) and that the levels
of NGF are significantly decreased in the cholinergic basal
forebrain of AD brains (Mufson et al., 1995). NGF deficits are
proved to be correlated both to amyloidogenic APP processing
(Capsoni et al., 2002; Matrone et al., 2009) and to synaptic
impairment (Lagostena et al., 2010) in cellular and animal
AD models, further supporting the “neurotrophic unbalance”
hypothesis as underlying trigger of AD-like neurodegeneration
(Francis et al., 1999; Cattaneo and Calissano, 2012). Interestingly,
in addition to loss of synapses, synaptic function is also
affected in AD pathology by decrements in transcript species
related to presynaptic vesicles trafficking, as shown by gene
expression profiling on affected brain areas (Mufson et al., 2002;
Coleman and Yao, 2003; Yao, 2004; Ginsberg et al., 2006).
The patterns (amplitude/frequency) of spontaneous mEPSC,
playing important roles in maintaining functional connections
of synapses, has been suggested to tag selected synapses for the
occurrence of metaplasticity, reflecting long-term consequences
of prior synaptic activity or experience (Zhang et al., 2005).
Furthermore, our findings on the coordinate NGF-dependent
regulation of selected presynaptic proteins involved in vesicles
trafficking and of neurontransmitter exocytosis are supported
by previous studies reporting that the application of either
NGF or TrkA NGF-mimetic agonists successfully rescues the
loss of cortical cholinergic boutons in impaired old rats
(Cuello et al., 2007), in AD mice models (Aboulkassim et al.,
2011; Capsoni et al., 2012) and in humans (Tuszynski et al.,
2005; Rafii et al., 2014). Interestingly, the CSF increased
levels of several synaptic proteins -including those involved
in vesicles trafficking and neurotransmitter exocytosis- have
recently turned out to be useful in monitoring the early
synaptic degeneration in correlation with the rate of cognitive
impairment of AD subjects at pre-symptomatic stages of
neuropathology, representing thus a novel potential diagnostic
and prognostic biomarker in clinical practice (Davidsson et al.,
1999; Jahn et al., 2011; Kvartsberg et al., 2015; Öhrfelt et al.,
2016).
Taken together, our studies demonstrating that NGF
deprivation acts directly and locally on neurosecretory function
of cholinergic presynaptic terminals via TrkA-activation by
controlling the steady state levels of synapsin I, SNAP25 and
α-synuclein provide for the first time an in vitro system model
to elucidate the direct interplay between the lack of trophic
supply and the early synapses derangement which is causally
associated with neurodegeneration and aging. Furthermore, our
findings can hopefully have important clinical implications in the
fields of therapeutical in vivo NGF delivery in humans because
not only constitute a molecular rationale for the existence of
its limited therapeutic time window but also offer a prime
useful presynaptic-based target with the intent of extending its
neuroprotective action in AD intervention.
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